Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fucithalmic

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Objective: To investigate the therapeutic effect of Fucithalmic 1%, Sofinox 0.5% and 1% eye drops against an IgE-mediated… Expand
  • table 4
  • table 1
  • table 3
2010
2010
  • S. Hansen
  • European Journal of Drug Metabolism and…
  • 2010
  • Corpus ID: 7125844
SummaryFucithalmic® is a newly developed 1% microcrystalline suspension of the antistaphylococcal antibiotic fusidic acid… Expand
  • table I
2010
2010
SummaryFusidic acid viscous eye drops, Fucithalmic (R), is a new eye antibiotic preparation which shows sustained-release… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2006
2006
Abstract This article outlines the clinical features and management of the basic eye conditions that every general practitioner… Expand
2002
2002
PURPOSE To compare the clinical and bacteriological effects of fucidic acid (Fucithalmic: 1.0%) and chloramphenicol (Minims(R): 0… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
1998
1998
PURPOSE To compare the healing of the cornea and the incidence of infection after traumatic corneal epithelial defect after… Expand
1992
1992
Abstract One hundred and four children undergoing strabismus surgery were randomised post‐operatively to one of three treatment… Expand
1987
1987
  • M. Dirdal
  • Acta ophthalmologica
  • 1987
  • Corpus ID: 42815061
Abstract Fucithalmic®, which is 1% fusidic acid in a sustained‐release eye preparation, was shown to be superior to both… Expand